GeneGo Launches New Web Site With Free Pathways for the Biology and Chemistry Community
ST. JOSEPH, Mich., Oct. 29 /PRNewswire/ — GeneGo, Inc., the leading systems biology tools company, announced today that they will be launching a new web site with FREE high quality pathway content. On www.genego.com, anyone can now search for genes, proteins, compounds, processes and diseases and access high quality manually curated pathway maps for human, mouse and rat signaling and metabolism. Every step on the pathways is supported by high quality “small experiment” evidence. The web site includes 37 Cystic Fibrosis specific disease maps, the result of a collaborative development project with Cystic Fibrosis Foundation (CFF).
GeneGo’s new web site also features a new community career section http://www.genego.com/careers.php that anyone can advertise open positions at their companies or institutions. Furthermore, the web site also includes sections with the latest publications using GeneGo technology; it can be searched and there is also product information, events and training sessions on line and at many locations throughout the world.
“With the number of our academic users growing rapidly and GeneGo working with companies to set industry standards, we wanted to ‘give back’ to the life science community that has been loyal to GeneGo for years,” said Julie Bryant, GeneGo’s VP of Business development. “For the first time, we are now providing free pathway maps that have been expensive to build and a section to help people find jobs in these tough times. We plan to add more ‘community services’ in the next 12 months.”
About GeneGo, Inc.
GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 6.0(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 6.0(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company’s web site at www.genego.com .
